Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer
The Effectiveness of Mukbang in Helping Children With Cancer Hospitalized for Radiotherapy and Chemotherapy to Improve Appetite, Nutritional Status and Quality of Life: A Randomized Control Trial
Wei XIA, PhD
124 participants
Dec 16, 2024
INTERVENTIONAL
Conditions
Summary
This study aims to use a two arms randomized clinical trial study to evaluate the effectiveness of the effective constituent of Mukbang in helping children with cancer hospitalized for radiotherapy and chemotherapy to improve their appetite, nutritional status and quality of life.
Eligibility
Inclusion Criteria4
- Aged between 6 to 18 years old;
- Children in accordance with the guidelines for the Diagnosis and Treatment of 12 Diseases related to hematologic diseases and malignant tumors (2021 version) issued by the General Office of the National Health Commission;
- At least experience one full cycle of chemotherapy;
- Children with moderate or higher symptoms of decreased appetite were screened for a list of treatment-related symptoms.
Exclusion Criteria2
- Children with serious cardiopulmonary disease, infection, organ damage, or genetic metabolic disease, immune deficiency disease, mental illness;
- Children with eye or ear dysfunction that prevents them from watching and listening to videos.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Mukbang videos include the items which can truly improve the appetite of children with cancer, such as food images, eating sound and interactivity.
Short videos that don't contain any food cues.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05922553